Evidence map›Paper›PMID 38191666›Full record

ArticleBlood advances2024

FANCA c.3624C>T (p.Ser1208=) is a hypomorphic splice variant associated with delayed onset of Fanconi anemia.

Ramanagouda Ramanagoudr-Bhojappa, Rebecca Tryon, Francis P Lach, Frank X Donovan, Rochelle Maxwell, Allana Rosenberg, Margaret L MacMillan, John E Wagner, Arleen D Auerbach, Agata Smogorzewska and 1 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Tracking Cytopenias inmedRxiv : the preprint server for health sciences · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ramanagouda Ramanagoudr-BhojappaCancer Genomics Unit, Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.ORCID 0000-0002-3122-3827
Rebecca TryonDepartment of Genetics, University of Minnesota, Minneapolis, MN.ORCID 0000-0003-4504-128X
Francis P LachLaboratory of Genome Maintenance, The Rockefeller University, New York, NY.
Frank X DonovanCancer Genomics Unit, Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.ORCID 0000-0002-7712-2335
Rochelle MaxwellLaboratory of Genome Maintenance, The Rockefeller University, New York, NY.ORCID 0000-0002-2942-0645
Allana RosenbergLaboratory of Genome Maintenance, The Rockefeller University, New York, NY.
Margaret L MacMillanDivision of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN.
John E WagnerDivision of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN.
Arleen D AuerbachHuman Genetics and Hematology Program, The Rockefeller University, New York, NY.
Agata SmogorzewskaLaboratory of Genome Maintenance, The Rockefeller University, New York, NY.ORCID 0000-0001-6285-1562
Settara C ChandrasekharappaCancer Genomics Unit, Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.ORCID 0000-0002-8084-0530
Rockefeller University · USNational Institutes of Health · USUniversity of Minnesota · US

Funding

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
POSITIONAL CLONING OF THE MEN1 GENEZIAHG000029 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI CHANDRASEKHARAPPA, SETTARA · 2009 to 2025
$13.3M
The role of nucleases in interstrand crosslink repairR01HL120922 · NHLBI · ROCKEFELLER UNIVERSITY · PI SMOGORZEWSKA, AGATA · 2014 to 2018
$2.1M
Functions of human RAD51 and its paralogs during DNA interstrand crosslink repairR01CA204127 · NCI · ROCKEFELLER UNIVERSITY · PI SMOGORZEWSKA, AGATA · 2017 to 2021
$2.0M
NCATS NIH HHS UL1 TR001866NCI NIH HHS R01 CA204127NHLBI NIH HHS R01 HL120922
6 · The paper itself

Abstract

abstractFanconi anemia (FA) is a hereditary, DNA repair deficiency disorder caused by pathogenic variants in any 1 of 22 known genes (FANCA-FANCW). Variants in FANCA account for nearly two-thirds of all patients with FA. Clinical presentation of FA can be heterogeneous and include congenital abnormalities, progressive bone marrow failure, and predisposition to cancer. Here, we describe a relatively mild disease manifestation among 6 individuals diagnosed with FA, each compound heterozygous for 1 established pathogenic FANCA variant and 1 FANCA exon 36 variant, c.3624C>T. These individuals had delayed onset of hematological abnormalities, increased survival, reduced incidence of cancer, and improved fertility. Although predicted to encode a synonymous change (p.Ser1208=), the c.3624C>T variant causes a splicing error resulting in a FANCA transcript missing the last 4 base pairs of exon 36. Deep sequencing and quantitative reverse transcription polymerase chain reaction analysis revealed that 6% to 10% of the FANCA transcripts included the canonical splice product, which generated wild-type FANCA protein. Consistently, functional analysis of cell lines from the studied individuals revealed presence of residual FANCD2 ubiquitination and FANCD2 foci formation, better cell survival, and decreased late S/G2 accumulation in response to DNA interstrand cross-linking agent, indicating presence of residual activity of the FA repair pathway. Thus, the c.3624C>T variant is a hypomorphic allele, which contributes to delayed manifestation of FA disease phenotypes in individuals with at least 1 c.3624C>T allele.

Indexed as

Fanconi AnemiaNeoplasmsCell LineFanconi Anemia Complementation Group A ProteinGenotypeHumansFANCA protein, humanFanconi Anemia Complementation Group A Protein

Identifiers

PMID38191666
PMCPMC10875269
OpenAlexW4390684781

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.